Product Information
SERTRALINE 150 MG CAPSULE is a generic product labeled by Almatica Pharma LLC, priced at $1.2507 per EA under NDC 52427066430. Its NADAC has been published 233 times since Apr 20, 2022.
FDA first approved this application on Oct 4, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427066430
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA215133FDA Approved
10/4/2021
TE Code
AB
On Market Since
10/4/2021
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE 150 MG CAPSULE has been published 233 times since Apr 20, 2022, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2507 per EA |
|---|---|
| All-time high | $5.1842 (Dec 11, 2024) |
| All-time low | $1.2507 (Sep 23, 2026) |
| 52-week high | $5.1702 |
| 52-week low | $1.2507 |
| Median price | $4.9135 |
| Average price | $4.6706 |
| Largest weekly change | -33.8% (Jul 22, 2026) |
| Weeks tracked | 233 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Almatica Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sertraline hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SERTRALINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 150 MG CAPSULE, manufactured by Almatica Pharma LLC, is $1.2507 per EA (NDC 52427066430), effective Sep 30, 2026.
How has the price of SERTRALINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SERTRALINE 150 MG CAPSULE has declined 73.2%. It has been tracked across 233 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for SERTRALINE 150 MG CAPSULE?
Since Apr 20, 2022, the NADAC for SERTRALINE 150 MG CAPSULE has ranged from a low of $1.2507 (Sep 23, 2026) to a high of $5.1842 (Dec 11, 2024), with a median of $4.9135 per EA.
Are there cheaper alternatives to SERTRALINE 150 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SERTRALINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures SERTRALINE 150 MG CAPSULE?
SERTRALINE 150 MG CAPSULE (NDC 52427066430) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.